|Listing||SIX Swiss Exchange|
|Security type||Registered share|
|Nominal value||CHF 1 per share|
(from September 21, 2020)
|SXI Life Sciences® (SIX/Bloomberg: SLIFEX)
SXI Bio+Medtech® (SIX/Bloomberg: SBIOMX)
|Ordinary share capital 2||CHF 14,195,072|
|Authorized capital 2||CHF 4,030,000|
|Conditional capital for financings 1||CHF 4,389,991|
|Conditional capital for employee participation plans 2|| CHF 687,052|
|1 following the AGM 2020 of April 22, 2020|
2 as per the Articles of Incorporation of August 10, 2020
李宗㟨精品72集,黄图能看见奶头The Company reports changes in its conditional capital to the SIX Swiss Exchange on a monthly basis. Such changes are in most cases the result of an exercise of share appreciation rights or stock option rights.
李宗㟨精品72集,黄图能看见奶头Details are available under “Company Details” > “Capital Structure”.
Significant shareholdings in Santhera can be viewed .
李宗㟨精品72集,黄图能看见奶头Santhera has mandated areg.ch to maintain the Company's share register.
Phone +41 62 209 16 60
Fax +41 62 209 16 69